RenalGuard Solutions
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
459 Fortune Blvd, Milford, Massachusetts...Phone Number
(508) 541-8800Website
www.renalguard.comRevenue
$10 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About RenalGuard Solutions
CardioRenal Systems, Inc. specializes in innovative medical technology aimed at preventing Acute Kidney Injury (AKI) in various clinical settings, particularly during cardiac surgery. Their flagship product, RenalPro, is an FDA designated breakthrough device that autonomously manages fluid therapy and integrates seamlessly into clinical workflows. The system has demonstrated significant efficacy in reducing AKI rates, showcasing a 52% reduction in a clinical study. The company targets healthcare providers and institutions seeking advanced solutions for kidney protection and fluid management.Explore more
RenalGuard Solutions Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RenalGuard Solutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if RenalGuard Solutions had a recent Job posting/layoffs
Check out if RenalGuard Solutions is spiking on competitors!
RenalGuard Solutions, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when RenalGuard Solutions launches new products
Congratulate Masked Content for being promoted to Masked Content at RenalGuard Solutions
Earning: See what the market has to say on RenalGuard Solutions recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once RenalGuard Solutions has new funding data
Check if RenalGuard Solutions has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined RenalGuard Solutions as Masked Content
Find 3 more new buyers
Compare Similar Companies to RenalGuard Solutions
Compare insights from companies similar to RenalGuard Solutions, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RenalGuard Solutions is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RenalGuard Solutions is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RenalGuard Solutions.
RenalGuard Solutions financials insights
Gather financial insights about RenalGuard Solutions, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$7M
RenalGuard Solutions Tech Stack
A closer look at the technologies used by RenalGuard Solutions
RenalGuard Solutions News & Media
KIDNEY Clinical Trial Results: RenalGuard Therapy ® Prevents Acute Kidney Injury After Cardiac Surgery
Automated Diuresis technology; trial results published in European Journal of Cardio-Thoracic SurgeryClinical Data from Reprieve Cardiovascular's Successful First-in-Human Therapy for Acute Heart Failure Presented
MILFORD, Mass., Dec. 13, 2019 /PRNewswire/ -- Reprieve Cardiovascular®, a pioneering medical device company focused on improving outcomes for patients suffering from acute decompensated heart failure (ADHF), today announced the results of the first-in-human clinical trial with the...Late-Breaking KIDNEY Clinical Trial Results: RenalGuard Therapy Prevents Acute Kidney Injury After Cardiac Surgery
MILFORD, Mass., Nov. 7, 2019 /PRNewswire/ -- RenalGuard Solutions™, a pioneering medical device company focused on protecting patients from acute kidney injury (AKI), announced today that the KIDNEY clinical trial confirmed RenalGuard Therapy® better protects at-risk patients undergoing...Late-Breaking KIDNEY Clinical Trial Results: RenalGuard Therapy Prevents Acute Kidney Injury After Cardiac Surgery
Automated Diuresis Technology; Trial Results Presented at American Society of Nephrology 2019
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RenalGuard Solutions
Sign Up For FreeTo access detailed company insights
CardioRenal Systems, Inc. specializes in innovative medical technology aimed at preventing Acute Kidney Injury (AKI) in various clinical settings, particularly during cardiac surgery. Their flagship product, RenalPro, is an FDA designated breakthrough device that autonomously manages fluid therapy and integrates seamlessly into clinical workflows.... Read More
